Urokinase is a neutral protease whose major site of action is the external surface of the plasma membrane of cells and whose major function seems to be modulation of cell adhesion, such as that which occurs during cell migration. This study aimed to determine whether colonic epithelium is involved with the urokinase system. The contents ofurokinase and one of its specific inhibitors, plasminogen activator inhibitor-1, were measured in culture supernatant and cell homogenates of isolated human colonic crypt cells. The amounts of both factors increased in supernatants over 24 hours, and approximately twice the amount was found in supernatants than in autologous cell homogenates. The secretion of both factors was similar in serum free and serum containing media. Northern blot analysis showed that messenger ribonucleic acid specific for urokinase and plasminogen activator inhibitor-i was present in colonic crypt cells and that expression over 18 hours of culture was increased 12 fold for urokinase type plasminogen activator and two to fourfold for the inhibitor compared with values found in autologous freshly isolated cells. Urokinase activity was detected in crypt cell homogenates and supernatants indicating that it was present in excess of its inhibitors. Control experiments indicated that the epithelial cells themselves were responsible for the observations and excluded artefactual effects of the isolation procedure. In conclusion, isolated human colonic epithelial cells secrete urokinase and at least one of its specific inhibitors. Further investigation of the role of urokinase in the physiology and pathophysiology of colonic epithelium is indicated. (Gut 1994; 35: Current knowledge of the relationship between the u-PA system and colonic epithelium is rudimentary. u-PA is present in mucosal homogenates and its content and activity increase in the presence of mucosal inflammation.6 7 Freshly isolated colonic crypts have cell associated u-PA activity and, in subcellular fractionation experiments, this co-localised with markers of the plasma membrane8 suggesting that colonic epithelial cells express u-PA receptors on their plasma membrane. In situ hybridisation experiments using human colonic mucosa from patients with large bowel cancer have demonstrated the expression of messenger ribonucleic acid (mRNA) for u-PA receptors in a very small proportion of colonic epithelial cells.9 It has not been established, however, whether the u-PA activity found associated with colonic epithelial cells derived from the epithelial cells themselves or from other cells. In situ experiments have found little evidence of mRNA for u-PA in normal colonic epithelium in humans or mice.9 10 The only evidence that colonic epithelial cells may be capable of secreting u-PA comes from studies of colon cancer cells lines which secrete u-PA and also express u-PA receptors.3 11
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NORTHERN BLOT ANALYSIS
Total RNA was extracted from both freshly isolated and cultured colonic crypt cell populations using the guanidium thiocyanate method.23 Total RNA (10 ,ug) was denatured with formamide and separated on 1-4% agarose-formaldehyde (2-2 molI1) gels. Ethidium bromide staining of the gel was used to assess the integrity and to monitor the loading of the RNA. After overnight (18 hour) transfer of the RNA to a nylon membrane (Zeta-Probe, BioRad, Richmond, CA), hybridisations were performed using a 1 2 kb human u-PA cDNA probe,24 labelled with 32P-dATP (specific activity 109 cpm ,g-1 ,ul-1) by random priming (Promega Corporation). All autoradiograms were exposed using two intensifying screens for four days at -70°C. Membranes were stripped by heating in a buffer containing 15 ,urmol/l sodium chloride, [1] [2] [3] [4] [5] (Fig 1) . After 24 hours' culture, the cell associated PAI-1 content (6-5 (1-5) ng/mg; n=20) was significantly less than that found in the supernatant (13 6 (3 3) ng/mg; p=0-013; paired t test). No differences in results were observed between cells from normal large bowel and those from cancer bearing bowels (Fig 2) . Comparison of PAI-1 values across the regions of the large bowel showed no significant differences. PAI-1 secretion was observed under serum free conditions and the level of secretion was not significantly different to that under serum containing conditions in 10 experiments (p= 0 16; Wilcoxon rank sum test; Fig 3) .
UROKINASE ACTIVITY IN COLONIC CRYPT POPULATIONS
To determine the relative amounts of u-PA and inhibitors present in supernatants and cell homogenates, u-PA activities after culture in serum free conditions were measured in a colorimetric assay specific for u-PA. u-PA activity was detected in all supernatants and cell homogenates tested, indicating that it was present in excess of inhibitors such as PAI-1. In 15 cell populations (eight normal and seven cancer), activity in the supernatant (7 5 (1 8) IU/g) tended to be greater than that in cell homogenates (4-8 (1 2 Table. Enzyme treatment led to a modest diminution of both secreted and cell associated u-PA and PAI-1 levels, indicating that the isolation procedure was unlikely to be inducing the secretion of u-PA and PAI-I by colonic crypts.
The contribution made by the non-epithelial minority population contaminating the colonic crypt preparation to the secreted u-PA value was investigated. Isolated lamina propria cells were produced by first stripping the mucosa of epithelium using EDTA and then processing the remaining lamina propria as for the crypt isolation. The resulting populations were contaminated with < 10% epithelial cells as assessed by morphology. In four experiments, the lamina propria cell associated content of u-PA (0-47 (0 20) ng/mg) and the amount secreted into the supernatants (1 -02 (0 20) ng/mg) was less than that of autologous colonic crypts (1-48 (0 80) ng/mg and 4 40 (2 04) ng/mg respectively). In three cell populations, the PAI-I content of the lamina propria cell homogenates (2-92 (1-30) ng/mg) and culture supematants (5.28 (2.45) ng/mg) were also measured and were also less than levels found in association with enriched colonic crypts (see above). These results indicate that the observations made with colonic crypt populations almost certainly reflected the behaviour of the majority cell population, the colonic epithelial cells.
Discussion
This study has shown that enriched isolated human colonic crypt cell populations from both normal and cancer bearing large bowel produce and secrete antigenically recognisable and enzymatically active u-PA. They also contain mRNA identified by a specific cDNA probe for u-PA. The u-PA found in the supernatants was not due solely to release of previously synthesised cellular u-PA or to lysis of the cells, since cell associated levels were about one third of those in the supernatant and colonic crypt cell populations remain viable over the culture period under the conditions used. 1618 u-PA secretion from cells was similar whether serum-free or serum-containing media was used. Of the u-PA produced by cultured crypt cells, little would have been contributed by the contaminating non-epithelial cells since they comprised a minority population in the isolated crypts and, more importantly, u-PA production from cultured lamina propria cells was 75% less (relative to cellular protein) than that for the autologous whole population. Furthermore, control experiments using LIM1863 cells showed that the isolation process was unlikely to be a stimulus to u-PA secretion but rather tended to suppress its secretion. These data indicate, therefore, that colonic epithelial cells themselves actively produce and secrete u-PA in vitro.
Parallel studies examining the appearance of one of the specific inhibitors of u-PA in supernatants of cultured crypt cells also showed constitutive secretion of PAI-1 by cells obtained from normal or cancer bearing colons. mRNA for PAI-1 was identified in RNA preparations from colonic crypts. As observed for u-PA, PAI-1 levels that were associated with crypt cell homogenates were, on average, about one half of those in autologous supematants after culture. Concomitant production of uPA and PAI-I by the same cell population has been documented for other types of epithelial cells such as keratinocytes and bronchial and alveolar epithelium. [27] [28] [29] Under the in vitro conditions used in the present study, the finding of net u-PA activity in cell supematants indicates that, in a functional sense, u-PA is being secreted in excess of its inhibitors. The poor correlation of u-PA, PAI-1, and u-PA:PAI-1 ratios with net u-PA activity suggests that PAI-I is not the only inhibitor secreted by colonic epithelium.
Whether constitutive secretion of u-PA and PAI-1 actually occurs in vivo remains uncertain since in situ methods that aim to detect proteins or mRNA suffer from poor sensitivity and, possibly, from technical problems such as the loss of u-PA during tissue preparation or poor affinity of antibodies to receptor bound u-PA. These problems are exemplified by the failure to demonstrate u-PA or PAI-I associated with normal colonic epithelium by immunohistochemistry. [30] [31] [32] [33] [34] [35] Similarly, in situ hybridisation experiments using human colonic tissue sections have not convincingly shown mRNA for u-PA in normal colonic epithelial cells.9 The present study has demonstrated that the accumulation of u-PA in supernatants accelerates after the first six hours of culture. This observation was consistent with the appreciable increase in expression of mRNA for u-PA relative to the total RNA in cells during culture. The mechanism underlying this induction of u-PA production is not clear. External soluble stimuli cannot be implicated since secretion of u-PA occurs in the absence of any such factors (that is, when cultured in medium containing buffers, nutrients, and antibiotics alone). The extraction process itself may be the trigger but experiments with LIM1863 cells did not show enzyme-induced u-PA secretion. The disruption of normal cell-substratum interaction or the relatively adverse nature of the in vitro conditions may themselves result in induction or acceleration of u-PA transcription. Alternatively, the removal of the cells from the influence of an in vivo suppressive factor(s) or the production in vitro of a stimulus from the cells themselves may be playing a role. The nature of any such factors requires elucidation.
u-PA may have particular relevance to the biology of colonic epithelium. Important components of its basement membrane (such as laminin, proteoglycan, and fibronectin) are known to be able to be digested by plasmin and by u-PA. The production of not only u-PA but also at least one of its specific inhibitors by colonic epithelium indicates that the epithelial cells have a potential in-built mechanism by which net u-PA activity on the cell surface can be modulated. Studies of promyeloid, fibroblastic, and sarcomatous cells and a malignant cell line of epithelial origin have found that u-PA receptors are localised at sites of cell-cell and cell-substratum contacts, whereas PAI-1 is diffusely distributed on the plasma membrane.3638 Membrane associated u-PA activity seems to play a critical role in cell motility of a number of motile cell types such as normal keratinocytes, fibroblasts, and monocytes,4 or in tissue invasion of cancer cells.27 Cell motility and tightness of cell-cell interactions are important in colonic epithelia. Changes in the activity of receptor bound u-PA might affect biological aspects that depend upon the strength of cell-cell and cellsubstratum contacts since they are intimately associated with protease sensitive molecules such as cadherins, laminin, and fibronectin. Loosening of these contacts might result in, for example, increased paracellular permeability, a change in the migration of cells from the base of the crypt to the surface, and increased loss of cells into the lumen. In colitis, paracellular permeation of luminal macromolecules through the epithelium into the lamina propria is increased,39 cell turnover is raised,40 and ulceration is characteristic; because mucosal u-PA content and activity are increased,6 7 u-PA may be responsible.
In conclusion, this study shows that human colonic epithelial cells freshly isolated from macroscopically normal large bowel secrete both u-PA and PAI-1. The presence of net u-PA activity in both supematants and cell homogenates indicates that under the in vitro culture conditions used, u-PA secretion may be greater than that of its inhibitors. In view of the current understanding of the biology of the u-PA system, these findings support the hypothesis that u-PA plays an important role in the normal physiology of colonic epithelium and in the pathophysiology of inflammatory and neoplastic diseases of the large bowel. 
